You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

TSC-101

Showing 1 - 25 of 755
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

AML, MDS, ALL, Adult Trial in Hackensack, New York (SOC + TSC-100, SOC + TSC-101, Control)

Recruiting
  • AML
  • +2 more
  • SOC + TSC-100
  • +2 more
  • Hackensack, New Jersey
  • +1 more
Aug 11, 2022

Tuberous Sclerosis Complex Trial in United States (Basimglurant with crossover to Placebo, Placebo with crossover to

Recruiting
  • Tuberous Sclerosis Complex
  • Basimglurant with crossover to Placebo
  • Placebo with crossover to Basimglurant
  • Phoenix, Arizona
  • +47 more
Jan 3, 2023

Tuberous Sclerosis Complex Trial in United States (Ganaxolone)

Enrolling by invitation
  • Tuberous Sclerosis Complex
  • Phoenix, Arizona
  • +13 more
Jan 24, 2023

TSC, Behavioral Symptoms Trial in Carrboro, Cincinnati (Behavioral Intervention in a small group platform)

Recruiting
  • TSC
  • Behavioral Symptoms
  • Behavioral Intervention in a small group platform
  • Carrboro, North Carolina
  • +1 more
Oct 23, 2023

Studies in Patients With Tuberous Sclerosis Complex

Recruiting
  • Tuberous Sclerosis Complex
    • Phoenix, Arizona
      Translational Genomics Research Institute (TGen)
    Oct 18, 2022

    Tuberous Sclerosis, Lymphangioleiomyomatosis Trial in Canada, United States (procedure, genetic, other)

    Recruiting
    • Tuberous Sclerosis
    • Lymphangioleiomyomatosis
    • Phlebotomy
    • +3 more
    • Birmingham, Alabama
    • +22 more
    Jan 6, 2023

    Advanced Malignant Solid Tumor, Ann Arbor Stage III Non-Hodgkin Lymphoma, Ann Arbor Stage IV Non-Hodgkin Lymphoma Trial in

    Recruiting
    • Advanced Malignant Solid Neoplasm
    • +44 more
    • Biopsy
    • +23 more
    • Birmingham, Alabama
    • +166 more
    Feb 2, 2023

    Interstitial Lung Disease Trial in Phoenix (Trans Sodium Crocetinate, Placebo)

    Terminated
    • Interstitial Lung Disease
    • Trans Sodium Crocetinate
    • Placebo
    • Phoenix, Arizona
      Pulmonary Associates, P.A.
    Aug 8, 2022

    Renal Angiomyolipoma Trial (Everolimus)

    Not yet recruiting
    • Renal Angiomyolipoma
    • (no location specified)
    Aug 15, 2022

    Growth and Development Trial in Belgium, Russian Federation, United States (Everolimus, Envirolimus drug class as prescribed by

    Active, not recruiting
    • Growth and Development
    • Everolimus
    • Envirolimus drug class as prescribed by Physician
    • Los Angeles, California
    • +5 more
    Dec 5, 2022

    Healthy Volunteers With Induced Hypoxia Trial in Durham (Trans Sodium Crocetinate)

    Completed
    • Healthy Volunteers With Induced Hypoxia
    • Trans Sodium Crocetinate
    • Durham, North Carolina
      Duke University Medical Center
    Apr 12, 2022

    Development of "T-sec" Questionnaire

    Not yet recruiting
    • Asthma
    • Questionnaire
    • (no location specified)
    Sep 20, 2022

    Chronic Hepatitis b Trial in Auckland (AB-101, Placebo, Nucleos(t)ide Analogue)

    Not yet recruiting
    • Chronic Hepatitis b
    • Auckland, New Zealand
      New Zealand Clinical Research Auckland
    Jul 26, 2023

    Tuberous Sclerosis Complex Associated Neuropsychiatric Disease Trial in United Kingdom, United States (Cannabidiol Oral Solution

    Not yet recruiting
    • Tuberous Sclerosis Complex Associated Neuropsychiatric Disease
    • Cannabidiol Oral Solution [Epidiolex]
    • Los Angeles, California
    • +6 more
    May 9, 2023

    Tuberous Sclerosis Complex, Seizures Trial in Worldwide (GWP42003-P, Placebo)

    Completed
    Has Results
    • Tuberous Sclerosis Complex
    • Seizures
    • Birmingham, Alabama
    • +43 more
    Sep 22, 2022

    Nasopharyngeal Carcinoma Trial in Wuhan (KSD-101)

    Not yet recruiting
    • Nasopharyngeal Carcinoma
    • KSD-101
    • Wuhan, China
      Tongji Hospital, Tongji Medical College, Huazhong University of
    Oct 19, 2023

    Solid Tumor Trial in China (BPB-101)

    Not yet recruiting
    • Solid Tumor
    • Guangzhou, Guangdong, China
    • +3 more
    May 11, 2023

    Frontotemporal Dementia, FTD, FTD-GRN Trial in Poland, Spain (Intrathalamic AAV.PGRN administration, Intrathalamic AVB-101)

    Recruiting
    • Frontotemporal Dementia
    • +3 more
    • Intrathalamic AAV.PGRN administration
    • Intrathalamic AVB-101
    • Katowice, Poland
    • +3 more
    Oct 6, 2023

    Nonalcoholic Fatty Liver Disease Trial in Jerusalem (Anti-human CCL24 mAb (CM-101) - Part One, Anti-human CCL24 mAb (CM-101) -

    Completed
    • Nonalcoholic Fatty Liver Disease
    • Anti-human CCL24 monoclonal antibody (CM-101) - Part One
    • +3 more
    • Jerusalem, Israel
      Hadassah University Hospital - Ein Kerem
    Sep 13, 2023

    Cancer Trial (Antibody-Drug Conjugate)

    Not yet recruiting
    • Cancer
    • Antibody-Drug Conjugate
    • (no location specified)
    Aug 23, 2023

    Tuberous Sclerosis Complex, Epilepsy Trial in United States (Sirolimus, Placebo)

    Recruiting
    • Tuberous Sclerosis Complex
    • Epilepsy
    • Birmingham, Alabama
    • +7 more
    Sep 2, 2022

    Community-acquired Pneumonia, Bacterial Pneumonia Trial in Cincinnati (CMTX-101, Placebo)

    Recruiting
    • Community-acquired Pneumonia
    • Bacterial Pneumonia
    • Cincinnati, Ohio
      Medpace Clinical Pharmacology Unit
    Jan 20, 2023

    Tuberous Sclerosis Complex Trial in Lodz, Warsaw (Rapamycin, Placebo)

    Not yet recruiting
    • Tuberous Sclerosis Complex
    • Rapamycin
    • Placebo
    • Lodz, Poland
    • +1 more
    Sep 6, 2022

    Epidermolysis Bullosa, Recessive Dystrophic Epidermolysis Bullosa, RDEB Trial in Redwood City, Worcester (EB-101 Surgical

    Not yet recruiting
    • Epidermolysis Bullosa
    • +2 more
    • EB-101 Surgical application of RDEB wounds
    • Redwood City, California
    • +1 more
    Feb 13, 2023

    Tuberous Sclerosis Trial in United States (Ganaxolone)

    Completed
    • Tuberous Sclerosis
    • Los Angeles, California
    • +6 more
    Oct 27, 2022